Mingchao Wang

Massachusetts General Hospital — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

17h-index1.1kcitations34works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(5), Cancer-related molecular mechanisms research(5), Circular RNAs in diseases(5), RNA modifications and cancer(4), Bladder and Urothelial Cancer Treatments(3)

Publications34 total

ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription Reprogramming
Journal of Clinical Investigation·2026Open Access
Protumor Macrophage Polarization Mediated by BMP2/4–ACVR1 Signaling Orchestrates an Immunosuppressive Microenvironment during Tumor Initiation
Cancer Research·2025
Gut microbe-derived metabolites drive psoriatic inflammation via modulation of skin Th17 cells
Immunity·2025· 9 cited
Utility of a novel and cost-effective biological model for percutaneous renal access training
Translational Andrology and Urology·2025Open Access
N-acetyltransferase 10 as a novel prognostic biomarker in papillary renal cell carcinoma: a machine learning and experimental validation study
Translational Cancer Research·2024· 1 citedOpen Access
Discovery of Oral AMP-Activated Protein Kinase Activators for Treating Hyperlipidemia
Journal of Medicinal Chemistry·2024· 3 citedOpen Access
The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma
Aging·2024· 1 citedOpen Access
RC48-Antibody-Drug Conjugate in Metastatic Urothelial Carcinoma: A Multicenter Real-World Study in China
Clinical Genitourinary Cancer·2024· 9 cited
An effective urobilin clearance strategy based on paramagnetic beads facilitates microscale proteomic analysis of urine
The Analyst·2024
MP Allosterically Activates AMPK to Enhance ABCA1 Stability by Retarding the Calpain-Mediated Degradation Pathway
International Journal of Molecular Sciences·2023· 3 citedOpen Access
ATR inhibition induces synthetic lethality in mismatch repair-deficient cells and augments immunotherapy
Genes & Development·2023· 30 citedOpen Access
METTL1 drives tumor progression of bladder cancer via degrading ATF3 mRNA in an m7G-modified miR-760-dependent manner
Cell Death Discovery·2022· 33 citedOpen Access
N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma
Molecular Cancer·2022· 96 citedOpen Access
Design of Bio-Responsive Hyaluronic Acid–Doxorubicin Conjugates for the Local Treatment of Glioblastoma
Pharmaceutics·2022· 35 citedOpen Access
Additional file 1 of N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma
Figshare·2022Open Access
Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway
International Journal of Biological Sciences·2022· 28 citedOpen Access
METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination
Molecular Therapy — Nucleic Acids·2021· 53 citedOpen Access
Intrinsic Abnormalities of Keratinocytes Initiate Skin Inflammation through the IL-23/T17 Axis in a MALT1-Dependent Manner
The Journal of Immunology·2021· 17 citedOpen Access
Correction to: Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating acrophages with alteration of the TIMP-1/MMP2/MMP9 signals
Molecular Cancer·2020Open Access
Circ-AKT3 inhibits clear cell renal cell carcinoma metastasis via altering miR-296-3p/E-cadherin signals
Molecular Cancer·2019· 184 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Gonghui Li(14), Liqun Xia(9), Xin Lin(6), Ruyue Wang(6), Lifeng Ding(6), Dingwei Xue(5), Yuanlei Chen(5), Danyang Shen(5), Zeyi Lu(5), Huan Wang(5), Wenqin Luo(5), Xueqiang Zhao(4), Liangliang Ren(4), Haiyun Xie(4), Jieyang Lu(3), Liwei Xu(3), Chawnshang Chang(3), Guoxing Zheng(3), Chenhao Yu(3), Shicheng Yu(3)